Capio

Capio was born in Silicon Valley at Carnegie Mellon University’s Speech@SV. It was here that Dr. Ian Lane – a leading authority in Speech Recognition, Natural Language Processing and Machine Learning – set out to redefine the way they communicate with the technologies around us.

Today, Capio is focused on developing the engine that drives all human-to-machine experiences. Based on years of research developed at CMU, they’ve engineered patented innovations that deliver unprecedented accuracy, reliability, insights and efficiency. Powered by the latest advancements in Machine Learning and High Performance Computing, their contextually-aware ASR solutions power applications across multiple industries, including Automotive, Robotics, Call Center, Voice Biometrics, Home Automation and Transcription.

At Capio, they create groundbreaking speech technologies that enable more natural human-machine interaction.

Capio, established in 2014 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Software, Service Industry, Health Care, Medical, Venture Capital, Financial Services, Business Development. Their recent investments include Doctrin, HealthCap, Swedbank Robur, Norrsken VC, Inbox Capital. The highest investment round they participated in was $925.8M. Among their most notable exits are Doctrin and HealthCap. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.